Search

everythinglearnresearchcommunity

for

Search:↓

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

A man's bald spot grew hair after starting cancer treatment with gefitinib.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Androgens increase growth factors in skin cells, which may lead to acne.

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.

Glycyrrhizic acid may help reduce unwanted hair growth.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

VEGF helps squamous cell carcinoma grow in ways beyond just blood vessel formation.

Drug repurposing shows promise for treating many medical conditions.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

JAK inhibitors offer new hope for treating severe alopecia areata.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Ruxolitinib treatment may cause eyelash growth.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Human liver cells stick to hair protein materials mainly through the liver's asialoglycoprotein receptor.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Cyclosporine-A can cause excessive hair growth, which usually stops after discontinuing the drug.

Newborn mouse skin cells can grow hair and this process can be recreated in adult cells to potentially help with hair loss.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Skin reactions from cancer treatments might predict how well the treatments work.

High levels of ERK activity are key for tissue regeneration in spiny mice, and activating ERK can potentially redirect scar-forming healing towards regenerative healing in mammals.

There is no cure for alopecia areata, but treatments like JAK inhibitors show promise.

EGF controls hair growth by regulating hair follicles' growth phases.

Researchers found genes and microRNAs that control curly fleece in Chinese Tan sheep.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.